Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Solna
Clinical trial register · Sweden

Clinical Trials in Solna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Karolinska Institutet16 AbbVie14 Bristol-Myers Squibb7 AstraZeneca6 Region Stockholm4
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Solna

113 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Walking and Thinking - Brain Activity During Complex Walking in Stroke
NCT07624630Stroke, Aging, Neuro-Degenerative Disease, Gait Impairment in Stroke Patients
Karolinska Institutet
Observational
50
Solna
2026-08-01
Recruiting
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
NCT07690436Transthyretin Amyloid Cardiomyopathy
AstraZeneca
Observational
500
Gothenburg, Solna, Vasterbottens Lan
2026-07-08
Recruiting
Prospective Natural History Study of POLG Disease
NCT07775872PolG, Primary Mitochondrial Myopathy
The POLG Foundation
Observational
300
Solna, Gothenburg
2026-06-17
Not yet open
University Hospital, Antwerp
Not applicable
266
Solna
2026-06-01
Recruiting
Smartwise Sweden AB
Phase 1/2
9
Solna
2026-04-29
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
135
Solna
2026-04-23
Not yet open
Charite University, Berlin, Germany
Phase 3
750
Solna
2026-04-01
Recruiting
Bristol-Myers Squibb
Phase 3
850
Gävle, Solna, Uppsala
2026-03-16
Active, closed
Gedea Biotech AB
Not applicable
48
Linköping, Solna, Uppsala
2026-03-03
Recruiting
Zealand Pharma
Phase 3
90
Gothenburg, Solna
2026-02-11
Active, closed
Hoffmann-La Roche
Phase 1
6
Mlndal, Solna
2026-01-27
Recruiting
AstraZeneca
Phase 3
1,100
Linköping, Lund, Solna, Umeå, Uppsala
2025-12-29
Recruiting
Björn Nordlund
Not applicable
50
Solna
2025-12-05
Recruiting
Novo Nordisk A/S
Phase 1
30
Malmö, Solna
2025-10-23
Recruiting
Bristol-Myers Squibb
Observational
223
Lund, Solna, Örebro
2025-10-08
Recruiting
HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC
NCT06830382Breast Cancer Stage IV, HER2-low Breast Cancer, Molecular Imaging
Renske Altena
Observational
70
Solna
2025-10-03
Not yet open
Effects and Implementation of a Brief Version of Parent-Child Interaction Therapy
NCT07201090Conduct Disorders in Children, Disruptive Behavior, Oppositional Defiant Disorder
Karolinska Institutet
Not applicable
15
Solna, Stockholm
2025-10-01
Not yet open
Evaluation of the Wheelchair School (Drivkraft) a Clinical Study
NCT07131553Neurological Disorders, Wheelchair Mobility, Rehabilitation
Karolinska Institutet
Not applicable
80
Solna
2025-10-01
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Solna, Gothenburg, Malmö
2025-09-30
Recruiting
Dr. Korman Laboratories Ltd.
Not applicable
75
Mölndal, Solna
2025-09-24
Recruiting
Sanofi
Phase 3
942
Solna
2025-09-16
Recruiting
Bristol-Myers Squibb
Phase 2
182
Solna, Gothenburg
2025-09-09
Recruiting
Karolinska Institutet
Observational
100
Solna
2025-09-01
Recruiting
University Hospital, Antwerp
Not applicable
50
Solna
2025-08-13
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Danderyd, Solna, Gothenburg
2025-08-11
Recruiting
AbbVie
Phase 3
120
Solna, Stockholm, Gothenburg
2025-07-28
Recruiting
AbbVie
Phase 1/2
325
Solna, Borås, Gothenburg
2025-07-23
Recruiting
Karolinska Institutet
Not applicable
50
Stockholm, Solna
2025-07-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Gothenburg, Lund, Solna
2025-07-02
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Falun, Gothenburg, Helsingborg, Lund, Norrköping, Solna, Stockholm
2025-06-25
Active, closed
AbbVie
Phase 3
573
Danderyd, Solna, Alingsås, Örebro, Linköping
2025-06-17
Recruiting
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
NCT07348263Eosinophilic Fasciitis
Meyer Children's Hospital IRCCS
Observational
20
Solna
2025-05-15
By invitation
QED Therapeutics, a BridgeBio company
Phase 2/3
24
Solna
2025-04-22
Not yet open
MRI Assesment of Cerebral Blood Flow in Anesthetized Children
NCT06886698Blood Flow, Cerebral Oxygenation, Blood Pressure
Karolinska Institutet
Observational
30
Solna
2025-04-15
Recruiting
AbbVie
Observational
2,000
Solna
2025-04-14
Recruiting
Step-by-Step: Evaluation of a Stepped Care Model
NCT06902649Child Behavior Problem, Disruptive Behavior, Oppositional Defiant Disorder, Conduct Problems
Karolinska Institutet
Not applicable
210
Solna
2025-04-02
Recruiting
Complications Related to the Anaesthesia During Airway Endoscopy in Children With Tracheostomy.
NCT06906263Anesthesia Complication, Tracheostomy Complications, Children Receiving General Anesthesia
Karolinska Institutet
Observational
80
Solna
2025-03-31
Recruiting
Daiichi Sankyo
Phase 3
510
Gothenburg, Solna
2025-03-27
Recruiting
[18F]ACI-15916 PET in α-synucleinopathies
NCT06891703Parkinson's Disease (PD), Multiple System Atrophy (MSA), Dementia With Lewy Bodies (DLB)
AC Immune SA
Early Phase 1
46
Solna
2025-03-20
Recruiting
Daiichi Sankyo
Phase 3
582
Lund, Solna, Uppsala
2025-03-19
Recruiting
Feeding Difficulties and Quality of Life in Children With Tracheal Cannula
NCT06893458Quality of Life (QOL), Tracheostomy, Children in the Pediatric Intensive Care Unit or General Pediatric Care Unit Requiring a Central Venous Catheter, Feeding Difficulties
Karolinska Institutet
Observational
80
Solna
2025-03-17
Active, closed
Karolinska Institutet
Not applicable
40
Solna
2025-03-15
Recruiting
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
NCT06906276Gait Disorders, Neurologic, Atypical Parkinson Disease, fNIRS, Aging
Karolinska Institutet
Observational
30
Solna
2025-03-14
Active, closed
Celgene
Phase 3
960
Lund, Solna, Uppsala, Gothenburg
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 1/2
413
Solna
2025-02-17
Active, closed
Sanofi
Phase 3
231
Lund, Solna, Stockholm
2025-02-12
Active, closed
Comparison of Different Oxygen Flow Rates During Preoxygenation Using High-Flow Nasal Oxygen
NCT06736132Airway Anesthesia, Preoxygenation, High Flow Nasal Canula
Region Stockholm
Not applicable
75
Solna
2025-01-13
Recruiting
The Leeds Teaching Hospitals NHS Trust
Observational
550
Gothenburg, Lund, Solna, Uppsala
2024-12-12
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Gothenburg, Solna, Umeå
2024-12-03
Recruiting
Region Stockholm
Observational
500
Solna
2024-10-22
Active, closed
AbbVie
Phase 3
1,400
Solna, Örebro
2024-06-27
Active, closed
Celgene
Phase 3
850
Lund, Solna, Uppsala, Linköping
2024-06-19
Recruiting
QED Therapeutics, a BridgeBio company
Observational
150
Solna
2024-06-05
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Solna
2024-05-28
Recruiting
Prolonged Exposure for Swedish Immigrants
NCT06193161Posttraumatic Stress Disorder
Karolinska Institutet
Not applicable
100
Solna
2024-03-15
Active, closed
AstraZeneca
Phase 2
142
Solna, Uppsala
2024-02-22
Recruiting
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
NCT06051240Cognitive Impairment, Cognitive Decline, Radiotherapy Side Effect, Radiotherapy; Complications
DrugLithium
Region Stockholm
Phase 2
84
Solna, Stockholm
2024-02-16
Recruiting
Karolinska Institutet
Not applicable
150
Solna
2024-01-08
Active, closed
Karolinska Institutet
Observational
12,599
Solna
2024-01-01
Active, closed
Sanofi
Phase 2
197
Solna, Stockholm
2023-12-11
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
NCT06131840Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma
DrugsLeucovorin·Adrucil·Oxaliplatin·Bevacizumab
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
914
Solna, Stockholm
2023-11-20
Active, closed
Genentech, Inc.
Phase 2
260
Gothenburg, Solna
2023-10-18
Recruiting
AbbVie
Phase 3
1,500
Solna, Stockholm, Mölndal
2023-10-11
By invitation
Biogen
Phase 3
306
Solna
2023-10-03
By invitation
argenx
Phase 3
240
Solna
2023-09-12
Active, closed
AbbVie
Phase 3
1,328
Solna, Gothenburg
2023-06-21
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
148
Gothenburg, Solna
2023-05-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Lund, Solna
2023-05-31
Recruiting
Prevention of Eating Disorders Through Optimization of Protective Factors
NCT05863598Body Dissatisfaction, Eating Disorders
Karolinska Institutet
Not applicable
644
Solna
2023-05-15
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Gothenburg, Linköping, Lund, Solna, Stockholm, Uppsala, Västerås
2023-03-09
Active, closed
Bristol-Myers Squibb
Phase 3
579
Solna, Lund
2023-03-06
Recruiting
Fore Biotherapeutics
Phase 2
254
Lund, Solna
2023-02-21
Active, closed
COMPASS Pathways
Phase 3
572
Landskrona, Lund, Solna, Stockholm
2023-02-14
Active, closed
Genmab
Phase 3
900
Lund, Solna, Borås, Gothenburg, Linköping
2023-02-08
Active, closed
Imperial College London
Phase 2
600
Solna
2023-01-25
Recruiting
Probiotic Supplementation in Extremely Preterm Infants in Scandinavia
NCT05604846Necrotizing Enterocolitis, Death, Sepsis Newborn, Feeding Disorder Neonatal
Region Stockholm
Not applicable
1,600
Solna
2022-12-16
Recruiting
AstraZeneca
Phase 3
3,527
Helsingborg, Huddinge, Lund, Malmö, Solna, Stockholm, Umeå, Västerås
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Solna, Stockholm
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Örebro, Solna, Stockholm
2022-07-22
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Lund, Solna
2022-04-14
Recruiting
AbbVie
Phase 3
768
Solna, Gothenburg
2022-03-25
Recruiting
Jan Calissendorff
Phase 3
182
Solna
2021-11-18
Recruiting
Biomarkers for Ventilator-associated Pneumonia
NCT05117125Pneumonia, Ventilator-Associated
Region Skane
Observational
1,000
Lund, Malmö, Solna
2021-10-15
Active, closed
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
NCT04907240Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access, Visceral Artery Aneurysms
W.L.Gore & Associates
Observational
614
Malmö, Solna
2021-10-09
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Solna, Uppsala
2021-08-30
Active, closed
AstraZeneca
Phase 3
893
Lund, Solna
2021-05-10
Active, closed
Incyte Corporation
Phase 3
654
Solna, Uddevalla, Uppsala
2021-04-15
Active, closed
Galderma R&D
Phase 3
500
Solna
2021-01-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Solna, Uppsala, Linköping
2021-01-10
Active, closed
Pfizer
Phase 3
841
Solna, Uppsala, Umeå, Gothenburg, Stockholm
2020-12-21
Active, closed
Genmab
Phase 1/2
543
Borås, Gothenburg, Lund, Solna, Uppsala
2020-11-03
Active, closed
AbbVie
Phase 3
527
Solna, Stockholm, Falun
2020-09-30
Recruiting
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
NCT04559425Heart Block Complete, Heart Block Second Degree
DrugDexamethasone
The Hospital for Sick Children
Observational
350
Gothenburg, Lund, Solna
2020-01-01
By invitation
Prospective Aortic Biobank of POP-STAR
NCT04269447Abdominal Aortic Aneurysm Without Rupture, Abdominal Aortic Aneurysm, Ruptured, Aortic Aneurysm, Aneurysm Abdominal
Karolinska University Hospital
Observational
400
Solna, Stockholm
2019-11-18
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Malmö, Solna
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Malmö, Solna
2019-10-21
Active, closed
Cecilia Soderberg-Naucler
Phase 2
220
Solna
2019-09-04
Recruiting
Uppsala University Hospital
Not applicable
75
Gothenburg, Lund, Örebro, Solna, Umeå, Uppsala
2019-09-01
Active, closed
AbbVie
Phase 3
964
Malmö, Falun, Solna, Uppsala, Västerås, Örebro
2019-03-25
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Falun, Jönköping, Örebro, Solna, Umeå
2019-03-21
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Solna
2019-02-08
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Gothenburg, Lund, Solna, Uppsala
2018-04-11
Active, closed
AbbVie
Phase 3
1,336
Malmö, Solna, Stockholm, Gothenburg
2018-04-09
Active, closed
AbbVie
Phase 3
747
Halmstad, Solna, Alingsås, Borås, Gothenburg
2018-03-21
Active, closed
Pfizer
Phase 3
1,054
Gothenburg, Solna, Umeå
2017-12-18
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Luleå, Borås, Solna
2017-05-22
Recruiting
Linkoeping University
Not applicable
100
Gothenburg, Linköping, Solna
2017-04-04
Active, closed
AGO Study Group
Not applicable
797
Lund, Solna
2016-07
Recruiting
Karolinska Institutet
Observational
20
Solna
2015-03-01
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
DrugBispecific
Partner Therapeutics, Inc.
Phase 2
250
Solna
2015-01
Active, closed
AbbVie
Observational
1,446
Solna, Stockholm
2014-08-28
Active, closed
AstraZeneca
Phase 3
1,837
Gothenburg, Linköping, Malmö, Solna, Stockholm, Umeå
2014-04-22
Active, closed
AbbVie
Observational
8,250
Solna, Stockholm, Uppsala, Gothenburg, Skövde
2013-04-29
Rows per page Showing 1–113 of 113
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/solna

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 113 of those studies with a site in Solna.

How many clinical trials are recruiting in Solna?

55 of the 113 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 5 have not yet opened recruitment, 47 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Solna), 113 studies
PhaseStudiesRecruitingShare
Phase 3451539.8%
Observational231720.4%
Not applicable181115.9%
Phase 213411.5%
Phase 1/2433.5%
Phase 2/3423.5%
Phase 1322.7%
Phase 4201.8%
Early Phase 1110.9%

Most active sponsors

Lead sponsors with the most studies (Solna)
Lead sponsorStudiesRecruiting
Karolinska Institutet1611
AbbVie145
Bristol-Myers Squibb75
AstraZeneca63
Region Stockholm43
Janssen Research & Development, LLC30
Novo Nordisk A/S31
QED Therapeutics, a BridgeBio company31
Sanofi31
Alnylam Pharmaceuticals21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.